Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000800560 | SCV000940284 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2022-10-27 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 187 of the AIRE protein (p.Ser187Leu). This variant is present in population databases (rs143952576, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. ClinVar contains an entry for this variant (Variation ID: 646302). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000800560 | SCV002083860 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-02-26 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003965594 | SCV004792378 | likely benign | AIRE-related disorder | 2023-12-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |